In both pre- and post-treatment, the injection of an epicatechin (30 mg/kg) dose dependently protects against transitory ischemia-induced brain injury through activation of the Nrf2/HO1 pathway in rodents [92]. The gene discussed is NFE2L2; the disease is ischemia.